Learn more at LeadIQ.com

Insights

Gathering insights about Erasca, Inc.…

Similar companies to Erasca, Inc.

Erasca, Inc. Tech Stack

Erasca, Inc. uses 8 technology products and services including Drupal, MySQL, jQuery, and more. Explore Erasca, Inc.'s tech stack below.

Drupal
Content Management System
MySQL
Database
jQuery
Javascript Libraries
Google Maps
Maps
Microsoft
Miscellaneous
HTTP/3
Miscellaneous
Yoast SEO
Search Engines
Bootstrap
UI Frameworks

Media & News

Erasca, Inc. launches program updates for pan-RAF inhibitor naporafenib and central nervous system -penetrant EGFR inhibitor ERAS-801.
SAN DIEGO, Nov. 28, 2023 (GLOBE NEWSWIRE) - Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced program updates for pan-RAF inhibitor naporafenib and central nervous system (CNS)-penetrant EGFR inhibitor ERAS-801, as well as a strategic program prioritization that extends its projected cash runway from H2 2025 to H1 2026.
Nov 27, 2023 | www.biospace.com
Connor, Clark & Lunn group invests into Erasca, Inc. $505K.
Connor Clark & Lunn Investment Management Ltd. invests $505,000 in Erasca, Inc. (NASDAQ:ERAS).
Aug 25, 2023 | www.etfdailynews.com
Erasca, Inc. launched Phase 1b data for ERAS-007 combinations on May 25th '23.
Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced preliminary Phase 1b data for ERAS-007 combinations in patients with GI malignancies from two poster presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
May 25, 2023 | www.globenewswire.com
Erasca, Inc. goes public.
As separately announced, Erasca has priced a $100 million equity offering with 15.38 million shares at $6.50/share.
Dec 09, 2022 | finance.yahoo.com
Erasca, Inc. partners with Eli Lilly and Company.
Erasca has previously inked deals with Eli Lilly and Pfizer — which owns the rights to Braftovi in the US and Canada — to study this combination as a treatment for patients with gastrointestinal malignancies in the ongoing Phase Ib/II HERKULES-3 trial.
Nov 30, 2022 | www.precisiononcologynews.com
Erasca, Inc. partnered with Pierre Fabre group on Nov 30th '22.
Erasca on Wednesday announced a partnership with Pierre Fabre to evaluate its investigational ERK1/2 inhibitor ERAS-007 with the BRAF inhibitor Braftovi (encorafenib) for BRAF V600E-mutant metastatic colorectal cancer.
Nov 30, 2022 | www.precisiononcologynews.com
Erasca, Inc. launched Phase 1/1b monotherapy data for ERK1/2 inhibitor ERAS-007 and SHP2 inhibitor ERAS-601 in BRAF-driven and RAS/MAPK-altered solid tumors on Sep 7th '22.
Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced promising preliminary Phase 1/1b monotherapy data for ERK1/2 inhibitor ERAS-007 and SHP2 inhibitor ERAS-601 in BRAF-driven and RAS/MAPK-altered solid tumors.
Sep 07, 2022 | finance.yahoo.com

Erasca, Inc.'s Email Address Formats

Erasca, Inc. uses at least 1 format(s):

Erasca, Inc. Email Formats	Example	Percentage
FLast@erasca.com	JDoe@erasca.com	50%
FLast@erasca.com	JDoe@erasca.com	50%

Frequently Asked Questions

Where is Erasca, Inc.'s headquarters located?

Erasca, Inc.'s main headquarters is located at 10835 Road to the Cure Suite 140 San Diego, California 92121 US. The company has employees across 1 continents, including North America.

What is Erasca, Inc.'s phone number?

You can contact Erasca, Inc.'s main corporate office by phone at

+1-858-465-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Erasca, Inc.'s stock symbol?

Erasca, Inc. is a publicly traded company; the company's stock symbol is ERAS.

What is Erasca, Inc.'s official website and social media links?

Erasca, Inc.'s official website is erasca.com and has social profiles on LinkedIn.

How much revenue does Erasca, Inc. generate?

As of September 2024, Erasca, Inc.'s annual revenue reached $15M.

What is Erasca, Inc.'s SIC code NAICS code?

Erasca, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Erasca, Inc. have currently?

As of September 2024, Erasca, Inc. has approximately 112 employees across 1 continents, including North America. Key team members include Chief People Officer: L. T.Chief Operating Officer: N. C.Chief Medical Officer: S. M.. Explore Erasca, Inc.'s employee directory with LeadIQ.

What industry does Erasca, Inc. belong to?

Erasca, Inc. operates in the Biotechnology Research industry.

What technology does Erasca, Inc. use?

Erasca, Inc.'s tech stack includes DrupalMySQLjQueryGoogle MapsMicrosoftHTTP/3Yoast SEOBootstrap.

What is Erasca, Inc.'s email format?

Erasca, Inc.'s email format typically follows the pattern of . Find more Erasca, Inc. email formats with LeadIQ.

How much funding has Erasca, Inc. raised to date?

As of September 2024, Erasca, Inc. has raised $184M in funding. The last funding round occurred on May 16, 2024 for $184M.

When was Erasca, Inc. founded?

Erasca, Inc. was founded in 2018.

Erasca, Inc.

Erasca, Inc.

Biotechnology ResearchCalifornia, United States51-200 Employees

Our mission at Erasca is embedded in our name: To erase cancer.

Energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology’s hardest problems. We have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals.

In addition to our initial programs for undisclosed cancer targets, we seek to expand our pipeline through partnerships with academic scientists and biopharmaceutical companies who have revealed potential new mechanisms for precision oncology. Importantly, Erasca isn’t tied to one form of drug or any singular approach to treating cancer. By keeping an open mind about what is possible, we believe we will achieve the greatest results for patients everywhere.

Company Overview

Headquarters: 10835 Road to the Cure Suite 140 San Diego, California 92121 US
Phone number: ✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-858-465-****
Website: erasca.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: ERAS
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2018
Employees: 51-200

Media & News

Funding & Financials

$184M
Erasca, Inc. has raised a total of $184M of funding over 7 rounds. Their latest funding round was raised on May 16, 2024 in the amount of $184M.
$10M$50M
Erasca, Inc.'s revenue is in the range of $10M$50M

Funding & Financials

$184M
Erasca, Inc. has raised a total of $184M of funding over 7 rounds. Their latest funding round was raised on May 16, 2024 in the amount of $184M.
$10M$50M
Erasca, Inc.'s revenue is in the range of $10M$50M

Company Leadership

L. T.
Chief People Officer
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. C.
Chief Operating Officer
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. M.
Chief Medical Officer
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. L.
Chief Regulatory Affairs Officer
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. W.
Executive Assistant To Chief Executive Officer
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

R. C.
Vice President, Business Development
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
L. B.
Senior Vice President Clinical Development
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. Z.
Vp, Head Of Spa And Cdm, Biometrics
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. V.
Vp Of Chemistry
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. A.
Vice President, Portfolio And Program Leadership
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Erasca, Inc. and Millions of Other Companies
Sign up for full access to Erasca, Inc. information. No credit card needed.
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.